BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16284630)

  • 1. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy.
    De Clercq E; Field HJ
    Br J Pharmacol; 2006 Jan; 147(1):1-11. PubMed ID: 16284630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclic nucleosides as antiviral compounds.
    Freeman S; Gardiner JM
    Mol Biotechnol; 1996 Apr; 5(2):125-37. PubMed ID: 8734425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
    Anand B; Nashed Y; Mitra A
    Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
    Sinokrot H; Smerat T; Najjar A; Karaman R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
    [No Abstract]   [Full Text] [Related]  

  • 7. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
    Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
    Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
    Chakrabarty A; Tyring SK; Beutner K; Rauser M
    Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting.
    Li F; Maag H; Alfredson T
    J Pharm Sci; 2008 Mar; 97(3):1109-34. PubMed ID: 17696166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.
    Pertusati F; Serpi M; McGuigan C
    Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors.
    Hurwitz SJ; Schinazi RF
    Curr Opin HIV AIDS; 2013 Nov; 8(6):556-64. PubMed ID: 24100876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famciclovir for treatment of herpesvirus infections.
    Luber AD; Flaherty JF
    Ann Pharmacother; 1996 Sep; 30(9):978-85. PubMed ID: 8876860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
    Krecmerova M
    Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.
    Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK
    Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.
    De Clercq E; Andrei G; Snoeck R; De Bolle L; Naesens L; Degrève B; Balzarini J; Zhang Y; Schols D; Leyssen P; Ying C; Neyts J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):271-85. PubMed ID: 11563039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
    Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
    Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
    Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dancing with chemical formulae of antivirals: a personal account.
    De Clercq E
    Biochem Pharmacol; 2013 Sep; 86(6):711-25. PubMed ID: 23876344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.